Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database. // The Breast. – URL: https://www.sciencedirect.com/science/article/pii/S0960977626002432?dgcid=rss_sd_all
Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database. The Breast. https://www.sciencedirect.com/science/article/pii/S0960977626002432?dgcid=rss_sd_all
“Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database.” The Breast.
@article{article67556,
title = {Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database},
journal = {The Breast},
url = {https://www.sciencedirect.com/science/article/pii/S0960977626002432?dgcid=rss_sd_all}
}